Similarly, Zhang et al. [97] showed that serum POSTN levels had the potential to predict the efficacy of chemotherapy in patients with NSCLC [97] and could be used as an independent prognostic factor in this type of cancer. The gene discussed is POSTN; the disease is non-small cell lung carcinoma.